Cargando…

Natural killer cells in tumor immunotherapy

Detalles Bibliográficos
Autores principales: Wang, Dongyao, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476468/
https://www.ncbi.nlm.nih.gov/pubmed/37646229
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0215
_version_ 1785100939484463104
author Wang, Dongyao
Wei, Haiming
author_facet Wang, Dongyao
Wei, Haiming
author_sort Wang, Dongyao
collection PubMed
description
format Online
Article
Text
id pubmed-10476468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Compuscript
record_format MEDLINE/PubMed
spelling pubmed-104764682023-09-05 Natural killer cells in tumor immunotherapy Wang, Dongyao Wei, Haiming Cancer Biol Med Editorial Compuscript 2023-08-15 2023-08-26 /pmc/articles/PMC10476468/ /pubmed/37646229 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0215 Text en Copyright: © 2023, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Wang, Dongyao
Wei, Haiming
Natural killer cells in tumor immunotherapy
title Natural killer cells in tumor immunotherapy
title_full Natural killer cells in tumor immunotherapy
title_fullStr Natural killer cells in tumor immunotherapy
title_full_unstemmed Natural killer cells in tumor immunotherapy
title_short Natural killer cells in tumor immunotherapy
title_sort natural killer cells in tumor immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476468/
https://www.ncbi.nlm.nih.gov/pubmed/37646229
http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0215
work_keys_str_mv AT wangdongyao naturalkillercellsintumorimmunotherapy
AT weihaiming naturalkillercellsintumorimmunotherapy